GSK2983559 active metabolite
GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
Product Specifications
CAS Number
[1423186-80-4]
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/RIP2-kinase-inhibitor-1.html
Purity
98.86
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC(C)(C)S(C1=C(OCCO)C=C(N=CN=C2NC3=CC(N=CS4)=C4C=C3)C2=C1)(=O)=O
Molecular Formula
C21H22N4O4S2
Molecular Weight
458.55
References & Citations
[1]Linda N. Casillas, et al. Prodrugs of amino quinazoline kinase inhibitor. PCT Int. Appl. (2014), WO 2014043446 A1 20140320.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
RIPK2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human RNASE4 sgRNA gene knockout kit - Lentiviral human RNASE4 sgRNA gene knockout kit (25)
RFPL2 CRISPRa sgRNA lentivector (set of three targets)(Human)